Dr. Vikrant Brar, MD

NPI: 1346447729
Total Payments
$1,311
2024 Payments
$142.82
Companies
24
Transactions
53
Medicare Patients
1,689
Medicare Billing
$269,711

Payment Breakdown by Category

Food & Beverage$972.30 (74.2%)
Other$299.10 (22.8%)
Education$39.32 (3.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $972.30 48 74.2%
Long term medical supply or device loan $299.10 3 22.8%
Education $39.32 2 3.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $376.10 7 $0 (2023)
Genentech, Inc. $120.38 2 $0 (2024)
E.R. Squibb & Sons, L.L.C. $107.46 6 $0 (2022)
AstraZeneca Pharmaceuticals LP $106.16 6 $0 (2020)
Daiichi Sankyo Inc. $91.47 5 $0 (2022)
Genentech USA, Inc. $72.01 4 $0 (2020)
Amgen Inc. $62.64 3 $0 (2022)
Karyopharm Therapeutics Inc. $38.67 1 $0 (2020)
Puma Biotechnology, Inc. $32.04 2 $0 (2020)
Seagen Inc. $29.57 2 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $142.82 3 Genentech, Inc. ($120.38)
2023 $344.50 5 Novartis Pharmaceuticals Corporation ($323.81)
2022 $77.40 4 E.R. Squibb & Sons, L.L.C. ($24.50)
2021 $32.42 2 Global Blood Therapeutics, Inc. ($17.88)
2020 $430.38 22 AstraZeneca Pharmaceuticals LP ($56.38)
2019 $185.87 11 Genentech USA, Inc. ($37.92)
2018 $97.33 6 E.R. Squibb & Sons, L.L.C. ($30.21)

All Payment Transactions

53 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
08/01/2018 E.R. Squibb & Sons, L.L.C. SPRYCEL (Drug) Food and Beverage Cash or cash equivalent $12.75 General
Category: Oncology
04/24/2018 AstraZeneca Pharmaceuticals LP IMFINZI (Drug) Food and Beverage In-kind items and services $15.50 General
Category: Oncology
01/03/2018 PFIZER INC. SUTENT (Drug), INLYTA, BAVENCIO Food and Beverage In-kind items and services $11.97 General
Category: ONCOLOGY;RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 352 625 $191,300 $57,755
2022 6 444 843 $253,290 $81,257
2021 6 401 732 $173,972 $69,659
2020 8 492 796 $147,811 $61,041
Total Patients
1,689
Total Services
2,996
Medicare Billing
$269,711
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 203 396 $118,552 $36,470 30.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 57 98 $39,440 $12,690 32.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 41 57 $11,585 $3,448 29.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 22 22 $12,652 $3,232 25.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $5,099 $1,219 23.9%
96523 Irrigation of implanted venous access drug delivery device Office 2023 18 41 $3,972 $695.96 17.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 236 537 $159,489 $51,026 32.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 77 126 $50,400 $17,269 34.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 39 39 $22,269 $6,549 29.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 60 82 $16,482 $5,391 32.7%
96523 Irrigation of implanted venous access drug delivery device Office 2022 20 46 $4,416 $983.75 22.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 12 13 $234.00 $38.73 16.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 181 452 $103,715 $42,740 41.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 51 90 $30,601 $12,070 39.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 46 46 $21,503 $7,928 36.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 62 77 $11,328 $4,922 43.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $5,889 $1,844 31.3%
36415 Insertion of needle into vein for collection of blood sample Office 2021 46 52 $936.00 $153.00 16.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 180 410 $70,930 $33,840 47.7%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 54 54 $17,643 $8,793 49.8%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 50 67 $15,611 $7,110 45.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 52 73 $18,648 $3,419 18.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 49 57 $6,669 $3,077 46.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 16 31 $10,965 $2,588 23.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 24 27 $4,857 $1,092 22.5%

About Dr. Vikrant Brar, MD

Dr. Vikrant Brar, MD is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346447729.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikrant Brar, MD has received a total of $1,311 in payments from pharmaceutical and medical device companies, with $142.82 received in 2024. These payments were reported across 53 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($972.30).

As a Medicare-enrolled provider, Brar has provided services to 1,689 Medicare beneficiaries, totaling 2,996 services with total Medicare billing of $269,711. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Richmond, VA
  • Active Since 06/29/2007
  • Last Updated 08/03/2016
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1346447729

Products in Payments

  • Itovebi (Biological) $120.38
  • INJECTAFER (Drug) $65.07
  • OPDIVO (Biological) $50.35
  • DARZALEX (Biological) $47.59
  • Alecensa (Biological) $42.51
  • XPOVIO (Drug) $38.67
  • FASLODEX (Drug) $38.63
  • CALQUENCE (Drug) $38.53
  • EVENITY (Biological) $32.41
  • NERLYNX (Drug) $32.04
  • FOUNDATIONONE (Device) $28.31
  • ALIMTA (Drug) $28.05
  • ZEJULA (Drug) $26.61
  • Enhertu (Drug) $26.40
  • PIQRAY (Drug) $24.71
  • Pomalyst (Drug) $24.50
  • MONOFERRIC (Drug) $20.69
  • REBLOZYL (Biological) $19.86
  • TASIGNA (Drug) $18.79
  • OXBRYTA (Drug) $17.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Richmond